Pulse Biosciences (PLSE) Earnings Analysis

Pulse Biosciences (PLSE) has no confirmed upcoming earnings date. Last quarter (2026-05-04) it beat with EPS -0.27 USD vs -0.32 USD est (+15.6%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -30.06.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PLSE next report earnings?

No confirmed upcoming earnings date is currently scheduled for PLSE. This page updates as the calendar is published.

PLSE earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-04-0.27 USD-0.32 USD+15.6%Beat
2026-02-19-0.26 USD-0.265 USD+1.9%Beat
2024-10-30-0.16 USD-0.24 USD+33.3%Beat
2024-08-12-0.2 USD-0.24 USD+16.7%Beat

Beat rate: 4/4 (100%) over reported quarters with consensus data.

PLSE valuation and analyst view

Trailing P/E-30.06
Trailing EPS-1.09999 USD
Price / book33.50
Dividend yield0.00%
Market cap2.24B
Analyst consensusBuy (2 buy / 2 hold / 0 sell)
Avg price target32 USD

Related research pages

Frequently asked questions

When is Pulse Biosciences (PLSE)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for PLSE. This page updates as the calendar is published.

Did PLSE beat earnings last quarter?

In its 2026-05-04 report, PLSE posted EPS of -0.27 USD versus a -0.32 USD estimate — a beat of 15.6%.

What is PLSE's earnings track record?

Over the last 4 reported quarters with consensus data, PLSE beat estimates 4 times (100%).

What is PLSE's current P/E ratio and EPS?

PLSE trades at a trailing P/E of -30.06 on trailing EPS of -1.0999887193882856 USD.

What do analysts rate PLSE?

Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 32 USD.